Skip to content

Analysis of safety and efficacy of tubularless micropercutaneous nephroscopic channel assisted ureteroscopy in the treatment of incarcerated middle and lower ureteral calculi

Analysis of safety and efficacy of tubularless micropercutaneous nephroscopic channel assisted ureteroscopy in the treatment of incarcerated middle and lower ureteral calculi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103102
Enrollment
Unknown
Registered
2025-05-23
Start date
2025-05-23
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral calculi

Interventions

Tubeless percutaneous renal channel adjuvant therapy group (Group A):Tubeless percutaneous renal channel assisted therapy
Ureteroscopy group (Group B):None

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with incarcerated middle and lower ureteral calculi were clearly diagnosed Diagnostic criteria: 1). History (definite diagnosis) >=8 weeks 2). The stones did not move after two courses of stone removal or 4 to 6 weeks. 3). Transverse diameter >=0.8~1cm. 4). Moderate or higher hydronephrosis Pyelodissociation between 10 and 20mm with mild calyceal dilation is mild hydrops, pyelodissociation between 20 and 40mm with calyceal dilation is moderate hydrops, pyelodissociation greater than 40mm with significant calyceal dilation, disappearance of calyceal dome and significant pressure on renal parenchyma is severe hydrops. Normal renal cortical thickness is (6.45±1.63)mm, when the renal cortex is less than 4.35mm, it indicates cortical thinning. 5). Acute asthenia. The diagnosis of incarcerated ureteral calculi is valid if two of the above five conditions are present. 2.KUB or CT indicates that the stone is located in the middle and lower ureter. 3.The patient and his family agreed that the hospital should collect clinical data for research and analysis.

Exclusion criteria

Exclusion criteria: 1 Patients with incomplete clinical data and lost follow-up after surgery; 2 Patients with upper ureteral calculi; 3 Patients with major organ dysfunction can not tolerate surgery and uncontrolled systemic hemorrhagic disease; 4 Preoperative primary urinary system infection symptoms were not effectively controlled; 5 Severe urethral stricture, intracavitary surgery can not solve; 6 Hip deformity, lithotomy is difficult.

Design outcomes

Primary

MeasureTime frame
Gravel cleaning time;Total operating time;Postoperative blood transfusion rate;Incidence of postoperative interventional therapy;Incidence of postoperative sepsis;

Countries

China

Contacts

Public ContactShulian Chen

Department of Urology,Affiliated Hospital of Zunyi Medical University

cslzmu@163.com+86 189 8496 5855

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026